America’s Overdose Deaths Are Finally Falling. Arizona’s Are Climbing — and Two Federal Rules Land This Week That Make It Worse

At 6 p.m. in Phoenix in July, the asphalt is still giving back the day’s heat like an oven with the door left open, and a Maricopa County outreach van is doing what it does most evenings this month: pulling up along a wash or under an overpass, handing out water, and leaving behind a small nylon kit that looks like nothing — a sun hat, electrolyte packets, two doses of naloxone. The county calls them heat-relief kits, and it has handed out 1,700 of them so far this year. Two people are alive today, specifically, because a stranger had one of those kits on the night it mattered. July is not a metaphorical bad month for overdose in Maricopa County. It is, year after year, literally the deadliest one — heat and fentanyl compounding each other in a way that has nothing to do with willpower and everything to do with physiology.

Arizona is now paying a price the rest of the country just stopped paying.

Nationally, drug overdose deaths have fallen for three straight years. The CDC’s most recent provisional count — 69,147 deaths in the twelve months ending in January 2026 — is down 13.2% from a year earlier. That is roughly 10,000 fewer families getting the call. It is real progress, driven by wider naloxone access and the slow, unglamorous work of getting more people onto buprenorphine and methadone. If you have spent years bracing for a headline that only ever gets worse, that number is genuinely good news, and you’re allowed to feel some relief about it.

Arizona didn’t get the memo. While the country’s overdose count fell, Arizona’s rose — from an estimated 2,531 deaths in 2024 to roughly 2,988 in 2025, a jump of nearly 18%, with synthetic-opioid deaths specifically up around a third. Arizona and New Mexico now post the highest overdose death rates in the lower 48. Filter’s analysis of the same CDC data finds a sliver of a silver lining — Arizona’s rate of increase has been slowing, from 21% to roughly 8.2% in the most recent reading — but slowing while still rising is not the same story national headlines are telling about the rest of America.

The gap isn’t a mystery, and pretending it is wastes the time to close it

It is tempting to treat regional divergence like this as statistical noise, a quirk of small-state numbers or reporting lag. It isn’t. Arizona’s exposure runs on two tracks that other states don’t share in the same combination: a uniquely brutal climate that turns ordinary opioid use into a cardiovascular and thermoregulatory emergency for months at a time, and a supply chain that has real history here.

That history matters, and it’s worth fifteen seconds of it. Journalist Sam Quinones spent years documenting how black-tar heroin distribution networks — small crews out of Xalisco, Nayarit, delivering heroin door-to-door like pizza — built out their first American routes through the Southwest in the 1990s and 2000s, using Interstate 10’s cheap, direct corridor and Phoenix’s existing Mexican immigrant communities as connective tissue before the model went national. Arizona wasn’t a bystander to that first wave; it was infrastructure. The current shift researchers are watching — fentanyl powder increasingly replacing the pressed “M30” counterfeit pills that dominated Phoenix’s opioid supply — is a variation on a very old pattern: whatever changes about the drug, Arizona tends to feel it early and hard, because the roads and the routes were built here first.

Layer heat onto that supply exposure and the arithmetic gets worse. Fentanyl and other opioids dull the body’s ability to notice it’s overheating and to do anything about it — sweat less, breathe shallower, stay put in the sun instead of moving to shade — so a body that’s already fighting a 115-degree afternoon loses its early-warning system at the exact moment it needs it most. Maricopa County’s own reporting shows roughly 55% of heat-associated deaths in recent years involved drugs or alcohol. That’s not two separate emergencies running in parallel. It’s one emergency wearing two names, and it’s the same emergency Rize covered last week when the first wave of this data broke.

It’s one emergency wearing two names, and it’s the same emergency Rize covered last week when the first wave of this data broke.

The consequence, not the trigger warning: two rules that land days apart

Here’s the sentence that should stop a case manager mid-sentence this week: on July 31 — two days from today — a new federal Medicaid rule takes effect that makes it harder for people with substance use disorder to prove they’re too sick to be required to work in order to keep coverage.

Congress wrote a statutory carve-out exempting people with SUD from Medicaid work-reporting requirements. The Centers for Medicare & Medicaid Services’ interim final rule, as Georgetown University’s Center for Children and Families has laid out in detail, narrows that exemption anyway by requiring people to document that their condition “significantly impairs” their ability to meet the requirement — a threshold with no consistent clinical definition, applied by caseworkers with no consistent training, to a population whose engagement with paperwork is often the first thing a relapse disrupts. This is the implementation gate that matters: a federal statute saying SUD patients are exempt is not the same as a caseworker in Maricopa County approving that exemption on a Tuesday in August. The rule is real. Whether it works the way Congress intended is the open, unresolved question — and AHCCCS, Arizona’s Medicaid program, is the agency that will have to answer it for nearly two million enrollees.

The second rule is smaller in scope and, in its way, more insulting. In April, SAMHSA sent grantees a “Dear Colleague” letter — issued under an executive order titled “Ending Crime and Disorder on America’s Streets” — informing them that federal grant dollars can no longer be spent on fentanyl, xylazine, or medetomidine test strips. Local health departments and harm-reduction nonprofits are now scrambling for private and philanthropic funders to keep buying them.

SAMHSA just made it cheaper to die of not knowing than to know.

If you’ve ever dipped a strip into a cooker before you used, you already understand what that dollar buys: not permission, not encouragement — information, at the exact moment it’s the only thing standing between you and a dose you didn’t order. Test strips don’t manufacture drug use. They manufacture the ten extra seconds in which someone decides not to use alone, or not to use that batch at all. Cutting the federal check for a $1 strip while the supply keeps getting stranger — medetomidine now riding shotgun with fentanyl in city after city — is not a savings. It’s a transfer of risk onto exactly the people this week’s other rule is also making harder to insure.

What Arizona has, and hasn’t, done with the money it does have

This is the part of the Arizona Watch beat that’s easy to skip past because it’s about money instead of bodies — but the money is why the bodies keep piling up at a different rate here than everywhere else.

None of this is happening in a state with no resources. Arizona is receiving $1.215 billion over eighteen years from opioid litigation settlements — $526 million to the state, $669 million split across counties and cities — and Maricopa County just received its first payment, $4.7 million, in mid-July. AHCCCS has moved on harm reduction in real ways this year, distributing naloxone statewide and standing up an AI-assisted locator to help people find opioid use disorder providers faster. Catalina Behavioral Health, an Arizona provider, used the same July news cycle that produced the bad overdose numbers to publish a free naloxone guide for families — a small, useful thing, done quickly, by people who read the same data everyone else did and decided to act on it inside a week instead of a budget cycle.

That’s the model. Settlement money that funds a heat-relief kit or a locator tool is settlement money doing exactly what it was extracted from opioid manufacturers to do. Settlement money that sits in an account while the state debates strategy is money quietly failing the people it was meant to protect — and Arizona, with the country’s steepest overdose trajectory and among its largest per-capita settlement wallets, has the least excuse of any state to let that happen.

Settlement money that funds a heat-relief kit or a locator tool is settlement money doing exactly what it was extracted from opioid manufacturers to do.

What’s still true, and what to do with it this week

If you are the person this article is actually for — using, or newly not using, or six years into recovery and reading this because someone you love isn’t — here is what hasn’t changed: naloxone is still free, still federally funded, still legal for anyone to carry in Arizona, and it is still the single most effective tool that exists against exactly the risk this article describes. That did not get cut this week. Carry it. Ask for it at the county events handing out heat kits. It is one door that stayed open while two others swung partly shut.

If you’re a case manager or an AHCCCS-contracted provider, don’t wait for July 31 to find out what “significantly impairs” means in practice — get ahead of it this week by making sure every SUD client’s chart already documents functional impairment in the specific terms the interim rule will be graded on, before a renewal notice forces the conversation under worse conditions. If you sit anywhere near Arizona’s settlement fund decisions, ask, out loud, in the next meeting, why a state losing ground to overdose faster than almost anyone else in the country is still deciding rather than deploying.

The country caught a real break this year. Arizona’s data says, plainly, that the break didn’t arrive here — and two rules taking effect this week are betting that the people most exposed to that gap will simply absorb it quietly. Two thousand nine hundred eighty-eight families didn’t get to decide whether to absorb it quietly. Neither should the rest of us.